{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:37:42Z","timestamp":1792831062841,"version":"4.5.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY034686"],"award-info":[{"award-number":["EY034686"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["U24EY035102"],"award-info":[{"award-number":["U24EY035102"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R33EY032468"],"award-info":[{"award-number":["R33EY032468"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0579"],"award-info":[{"award-number":["W81XWH-20-1-0579"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0820"],"award-info":[{"award-number":["W81XWH-20-1-0820"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["HT9425-23-1-0608"],"award-info":[{"award-number":["HT9425-23-1-0608"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019592","name":"Veterans Administration Medical Center","doi-asserted-by":"publisher","award":["I01 CX002015"],"award-info":[{"award-number":["I01 CX002015"]}],"id":[{"id":"10.13039\/100019592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019592","name":"Veterans Administration Medical Center","doi-asserted-by":"publisher","award":["CX002633"],"award-info":[{"award-number":["CX002633"]}],"id":[{"id":"10.13039\/100019592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The cornea is among the most densely innervated tissues in the body and depends on intact sensory and autonomic innervation to maintain epithelial integrity, tear film homeostasis, and ocular surface defense. Corneal nerve injury may occur after surgery, infection, inflammation, trauma, or systemic disease and can lead to reduced corneal sensitivity, impaired epithelial healing, dry eye, neuropathic pain, and neurotrophic keratopathy. Effective management requires both treatment of the underlying cause and restoration of a microenvironment permissive for reinnervation. This review examines the mechanisms underlying corneal nerve injury and repair, with emphasis on therapeutic strategies relevant to clinical translation. These include anti-inflammatory and immunomodulatory agents, growth factors and cytokines, blood-derived products, extracellular matrix-based therapies, stem cell- and secretome-based approaches, surgical neurotization, and physical stimulation modalities. We also highlight emerging challenges in the field, including the gap between structural nerve regeneration and functional recovery, limitations in clinical evidence, and barriers to therapeutic accessibility and implementation.<\/jats:p>","DOI":"10.1007\/s40265-026-02396-w","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:55:44Z","timestamp":1791456944000},"page":"1857-1871","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Corneal Nerve Injury and Regeneration: Mechanisms, Clinical Consequences, and Emerging Therapeutic Strategies"],"prefix":"10.1007","volume":"86","author":[{"given":"Athar","family":"Shadmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3026-6155","authenticated-orcid":false,"given":"Anat","family":"Galor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houri","family":"Esmaeilkhanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Kostic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"2396_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.05.003","volume":"73","author":"MA Al-Aqaba","year":"2019","unstructured":"Al-Aqaba MA, Dhillon VK, Mohammed I, Said DG, Dua HS. Corneal nerves in health and disease. Prog Retin Eye Res. 2019;73:100762. https:\/\/doi.org\/10.1016\/j.preteyeres.2019.05.003.","journal-title":"Prog Retin Eye Res"},{"key":"2396_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0014-4835(03)00050-2","volume":"76","author":"LJ M\u00fcller","year":"2003","unstructured":"M\u00fcller LJ, Marfurt CF, Kruse F, Tervo TMT. Corneal nerves: structure, contents, and function. Exp Eye Res. 2003;76:521\u201342. https:\/\/doi.org\/10.1016\/S0014-4835(03)00050-2.","journal-title":"Exp Eye Res"},{"key":"2396_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/aos.13844","volume":"97","author":"M Labetoulle","year":"2019","unstructured":"Labetoulle M, Baudouin C, Calonge M, Merayo-Lloves J, Boboridis KG, Akova YA, et al. Role of corneal nerves in ocular surface homeostasis and disease. Acta Ophthalmol. 2019;97:137\u201345. https:\/\/doi.org\/10.1111\/aos.13844.","journal-title":"Acta Ophthalmol"},{"key":"2396_CR4","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s41385-018-0031-6","volume":"11","author":"Y Xue","year":"2018","unstructured":"Xue Y, He J, Xiao C, Guo Y, Fu T, Liu J, et al. The mouse autonomic nervous system modulates inflammation and epithelial renewal after corneal abrasion through the activation of distinct local macrophages. Mucosal Immunol. 2018;11:1496\u2013511. https:\/\/doi.org\/10.1038\/s41385-018-0031-6.","journal-title":"Mucosal Immunol"},{"key":"2396_CR5","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.exer.2009.12.010","volume":"90","author":"CF Marfurt","year":"2010","unstructured":"Marfurt CF, Cox J, Deek S, Dvorscak L. Anatomy of the human corneal innervation. Exp Eye Res. 2010;90:478\u201392. https:\/\/doi.org\/10.1016\/j.exer.2009.12.010.","journal-title":"Exp Eye Res"},{"key":"2396_CR6","doi-asserted-by":"publisher","first-page":"8543","DOI":"10.1167\/iovs.11-8113","volume":"52","author":"WR Kam","year":"2011","unstructured":"Kam WR, Sullivan DA. Neurotransmitter influence on human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci. 2011;52:8543\u20138. https:\/\/doi.org\/10.1167\/iovs.11-8113.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2396_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1167\/iovs.13-12642","volume":"55","author":"J-A Ko","year":"2014","unstructured":"Ko J-A, Mizuno Y, Ohki C, Chikama T, Sonoda K-H, Kiuchi Y. Neuropeptides released from trigeminal neurons promote the stratification of human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2014;55:125\u201333. https:\/\/doi.org\/10.1167\/iovs.13-12642.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2396_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1124\/mol.115.101014","volume":"89","author":"M S\u0142oniecka","year":"2016","unstructured":"S\u0142oniecka M, Le Roux S, Zhou Q, Danielson P. Substance P enhances keratocyte migration and neutrophil recruitment through interleukin-8. Mol Pharmacol. 2016;89:215\u201325. https:\/\/doi.org\/10.1124\/mol.115.101014.","journal-title":"Mol Pharmacol"},{"key":"2396_CR9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1167\/iovs.15-18019","volume":"57","author":"J He","year":"2016","unstructured":"He J, Bazan HE. Neuroanatomy and neurochemistry of mouse cornea. Invest Ophthalmol Vis Sci. 2016;57:664\u201374. https:\/\/doi.org\/10.1167\/iovs.15-18019.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2396_CR10","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.65.4.30","volume":"65","author":"L Ma","year":"2024","unstructured":"Ma L, Yang L, Wang X, Zhao L, Bai X, Qi X, et al. CGRP released by corneal sensory nerve maintains tear secretion of the lacrimal gland. Invest Ophthalmol Vis Sci. 2024;65:30. https:\/\/doi.org\/10.1167\/iovs.65.4.30.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2396_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2174\/13892037113149990046","volume":"14","author":"B Holzmann","year":"2013","unstructured":"Holzmann B. Antiinflammatory activities of CGRP modulating innate immune responses in health and disease. Curr Protein Pept Sci. 2013;14:268\u201374. https:\/\/doi.org\/10.2174\/13892037113149990046.","journal-title":"Curr Protein Pept Sci"},{"key":"2396_CR12","first-page":"692","volume":"41","author":"L You","year":"2000","unstructured":"You L, Kruse FE, V\u00f6lcker HE. Neurotrophic factors in the human cornea. Invest Ophthalmol Vis Sci. 2000;41:692\u2013702.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2396_CR13","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/stem.1942","volume":"33","author":"Q Zhou","year":"2015","unstructured":"Zhou Q, Chen P, Di G, Zhang Y, Wang Y, Qi X, et al. Ciliary neurotrophic factor promotes the activation of corneal epithelial stem\/progenitor cells and accelerates corneal epithelial wound healing. Stem Cells. 2015;33:1566\u201376. https:\/\/doi.org\/10.1002\/stem.1942.","journal-title":"Stem Cells"},{"key":"2396_CR14","first-page":"1063","volume":"41","author":"A Lambiase","year":"2000","unstructured":"Lambiase A, Manni L, Bonini S, Rama P, Micera A, Aloe L. Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas. Invest Ophthalmol Vis Sci. 2000;41:1063\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2396_CR15","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.63.2.4","volume":"63","author":"H Yun","year":"2022","unstructured":"Yun H, Yin X-T, Stuart PM, St. Leger AJ. Sensory nerve retraction and sympathetic nerve innervation contribute to immunopathology of murine recurrent herpes stromal keratitis. Invest Ophthalmol Vis Sci. 2022;63:4. https:\/\/doi.org\/10.1167\/iovs.63.2.4.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2396_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2022.109065","volume":"219","author":"F Li","year":"2022","unstructured":"Li F, Yu R, Sun X, Chen X, Xu P, Huang Y, et al. Autonomic nervous system receptor-mediated regulation of mast cell degranulation modulates the inflammation after corneal epithelial abrasion. Exp Eye Res. 2022;219:109065. https:\/\/doi.org\/10.1016\/j.exer.2022.109065.","journal-title":"Exp Eye Res"},{"key":"2396_CR17","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/sj.eye.6700616","volume":"17","author":"S Bonini","year":"2003","unstructured":"Bonini S, Rama P, Olzi D, Lambiase A. Neurotrophic keratitis. Eye (Lond). 2003;17:989\u201395. https:\/\/doi.org\/10.1038\/sj.eye.6700616.","journal-title":"Eye (Lond)"},{"key":"2396_CR18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2147\/OPTH.S45921","volume":"8","author":"M Sacchetti","year":"2014","unstructured":"Sacchetti M, Lambiase A. Diagnosis and management of neurotrophic keratitis. Clin Ophthalmol. 2014;8:571\u20139. https:\/\/doi.org\/10.2147\/OPTH.S45921.","journal-title":"Clin Ophthalmol"},{"key":"2396_CR19","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1097\/ICO.0000000000003248","volume":"42","author":"J Nortey","year":"2023","unstructured":"Nortey J, Tsang A, Lopez S, Gebreegziabher E, Keenan JD, Lietman T, et al. Central corneal sub-basal nerve plexus abnormalities in Sj\u00f6gren\u2019s disease: a pilot study. Cornea. 2023;42:1432\u20138. https:\/\/doi.org\/10.1097\/ICO.0000000000003248.","journal-title":"Cornea"},{"key":"2396_CR20","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1177\/1352458516677590","volume":"23","author":"J Mikolajczak","year":"2017","unstructured":"Mikolajczak J, Zimmermann H, Kheirkhah A, Kadas EM, Oberwahrenbrock T, Muller R, et al. Patients with multiple sclerosis demonstrate reduced subbasal corneal nerve fibre density. Mult Scler. 2017;23:1847\u201353. https:\/\/doi.org\/10.1177\/1352458516677590.","journal-title":"Mult Scler"},{"key":"2396_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/iovs.62.6.5","volume":"62","author":"L D\u2019Onofrio","year":"2021","unstructured":"D\u2019Onofrio L, Kalteniece A, Ferdousi M, Azmi S, Petropoulos IN, Ponirakis G, et al. Small nerve fiber damage and Langerhans cells in type 1 and type 2 diabetes and LADA measured by corneal confocal microscopy. Invest Ophthalmol Vis Sci. 2021;62:5. https:\/\/doi.org\/10.1167\/iovs.62.6.5.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2396_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45116-z","volume":"9","author":"M Ferdousi","year":"2019","unstructured":"Ferdousi M, Romanchuk K, Mah JK, Virtanen H, Millar C, Malik RA, et al. Early corneal nerve fibre damage and increased Langerhans cell density in children with type 1 diabetes mellitus. Sci Rep. 2019;9:8758. https:\/\/doi.org\/10.1038\/s41598-019-45116-z.","journal-title":"Sci Rep"},{"key":"2396_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.816062","volume":"13","author":"T Zhou","year":"2022","unstructured":"Zhou T, Lee A, Lo ACY, Kwok JSWJ. Diabetic corneal neuropathy: pathogenic mechanisms and therapeutic strategies. Front Pharmacol. 2022;13:816062. https:\/\/doi.org\/10.3389\/fphar.2022.816062.","journal-title":"Front Pharmacol"},{"key":"2396_CR24","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1016\/j.ophtha.2010.07.010","volume":"117","author":"P Hamrah","year":"2010","unstructured":"Hamrah P, Cruzat A, Dastjerdi MH, Zheng L, Shahatit BM, Bayhan HA, et al. Corneal sensation and subbasal nerve alterations in patients with herpes simplex keratitis: an in vivo confocal microscopy study. Ophthalmology. 2010;117:1930\u20136. https:\/\/doi.org\/10.1016\/j.ophtha.2010.07.010.","journal-title":"Ophthalmology"},{"key":"2396_CR25","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/archophthalmol.2010.187","volume":"128","author":"RC Young","year":"2010","unstructured":"Young RC, Hodge DO, Liesegang TJ, Baratz KH. The incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976 through 2007: the impact of oral antiviral prophylaxis. Arch Ophthalmol. 2010;128:1178\u201383. https:\/\/doi.org\/10.1001\/archophthalmol.2010.187.","journal-title":"Arch Ophthalmol"},{"key":"2396_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-981-15-8811-2_14","volume-title":"Infections of the cornea and conjunctiva","author":"SS Tuli","year":"2021","unstructured":"Tuli SS. Herpes zoster ophthalmicus (HZO) keratitis. In: Das S, Jhanji V, editors. Infections of the cornea and conjunctiva. Singapore: Springer; 2021. p. 211\u201324. https:\/\/doi.org\/10.1007\/978-981-15-8811-2_14."},{"key":"2396_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/eye.2011.270","volume":"26","author":"K Kurbanyan","year":"2012","unstructured":"Kurbanyan K, Hoesl LM, Schrems WA, Hamrah P. Corneal nerve alterations in acute Acanthamoeba and fungal keratitis: an in vivo confocal microscopy study. Eye (Lond). 2012;26:126\u201332. https:\/\/doi.org\/10.1038\/eye.2011.270.","journal-title":"Eye (Lond)"},{"key":"2396_CR28","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1136\/bjo.79.11.993","volume":"79","author":"LC Hieselaar","year":"1995","unstructured":"Hieselaar LC, Hogeweg M, de Vries CL. Corneal sensitivity in patients with leprosy and in controls. Br J Ophthalmol. 1995;79:993\u20135. https:\/\/doi.org\/10.1136\/bjo.79.11.993.","journal-title":"Br J Ophthalmol"},{"key":"2396_CR29","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3928\/1081-597X-20041101-08","volume":"20","author":"G Savini","year":"2004","unstructured":"Savini G, Barboni P, Zanini M, Tseng SCG. Ocular surface changes in laser in situ keratomileusis-induced neurotrophic epitheliopathy. J Refract Surg. 2004;20:803\u20139. https:\/\/doi.org\/10.3928\/1081-597X-20041101-08.","journal-title":"J Refract Surg"},{"key":"2396_CR30","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/ICL.0000000000000285","volume":"43","author":"E Lum","year":"2017","unstructured":"Lum E, Golebiowski B, Swarbrick HA. Reduced corneal sensitivity and sub-basal nerve density in long-term orthokeratology lens wear. Eye Contact Lens. 2017;43:218\u201324. https:\/\/doi.org\/10.1097\/ICL.0000000000000285.","journal-title":"Eye Contact Lens"},{"key":"2396_CR31","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1167\/iovs.11-8775","volume":"53","author":"J Sarkar","year":"2012","unstructured":"Sarkar J, Chaudhary S, Namavari A, Ozturk O, Chang J-H, Yco L, et al. Corneal neurotoxicity due to topical benzalkonium chloride. Invest Ophthalmol Vis Sci. 2012;53:1792\u2013802. https:\/\/doi.org\/10.1167\/iovs.11-8775.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2396_CR32","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jamaophthalmol.2013.5064","volume":"131","author":"A Lambiase","year":"2013","unstructured":"Lambiase A, Sacchetti M, Mastropasqua A, Bonini S. Corneal changes in neurosurgically induced neurotrophic keratitis. JAMA Ophthalmol. 2013;131:1547\u201353. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.5064.","journal-title":"JAMA Ophthalmol"},{"key":"2396_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.survophthal.2013.09.002","volume":"59","author":"BS Shaheen","year":"2014","unstructured":"Shaheen BS, Bakir M, Jain S. Corneal nerves in health and disease. Surv Ophthalmol. 2014;59:263\u201385. https:\/\/doi.org\/10.1016\/j.survophthal.2013.09.002.","journal-title":"Surv Ophthalmol"},{"key":"2396_CR34","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1136\/bjo.85.12.1455","volume":"85","author":"P Prabhasawat","year":"2001","unstructured":"Prabhasawat P, Tesavibul N, Komolsuradej W. Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation. Br J Ophthalmol. 2001;85:1455\u201363. https:\/\/doi.org\/10.1136\/bjo.85.12.1455.","journal-title":"Br J Ophthalmol"},{"key":"2396_CR35","doi-asserted-by":"publisher","first-page":"6404918","DOI":"10.1155\/2017\/6404918","volume":"2017","author":"T John","year":"2017","unstructured":"John T, Tighe S, Sheha H, Hamrah P, Salem ZM, Cheng AMS, et al. Corneal nerve regeneration after self-retained cryopreserved amniotic membrane in dry eye disease. J Ophthalmol. 2017;2017:6404918. https:\/\/doi.org\/10.1155\/2017\/6404918.","journal-title":"J Ophthalmol"},{"key":"2396_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s40123-017-0100-z","volume":"6","author":"JL Alio","year":"2017","unstructured":"Alio JL, Rodriguez AE, Ferreira-Oliveira R, Wr\u00f3bel-Dudzi\u0144ska D, Abdelghany AA. Treatment of dry eye disease with autologous platelet-rich plasma: a prospective, interventional, non-randomized study. Ophthalmol Ther. 2017;6:285\u201393. https:\/\/doi.org\/10.1007\/s40123-017-0100-z.","journal-title":"Ophthalmol Ther"},{"key":"2396_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2017.209","author":"S Rauz","year":"2017","unstructured":"Rauz S, Koay SY, Foot B, Kaye SB, Figueiredo F, Burdon MA, et al. The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: full report. Eye (Lond). 2017. https:\/\/doi.org\/10.1038\/eye.2017.209.","journal-title":"Eye (Lond)"},{"key":"2396_CR38","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s10792-017-0582-7","volume":"38","author":"RM Sanchez-Avila","year":"2018","unstructured":"Sanchez-Avila RM, Merayo-Lloves J, Riestra AC, Fernandez-Vega Cueto L, Anitua E, Bego\u00f1a L, et al. Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops. Int Ophthalmol. 2018;38:1193\u2013204. https:\/\/doi.org\/10.1007\/s10792-017-0582-7.","journal-title":"Int Ophthalmol"},{"key":"2396_CR39","doi-asserted-by":"publisher","DOI":"10.1097\/coa.0000000000000029","volume":"3","author":"A Abazari","year":"2024","unstructured":"Abazari A, Abbouda A, Cruzat A, Cavalcanti B, Pavan-Langston D, Hamrah P. Corneal reinnervation in patients with severe neurotrophic keratopathy secondary to herpes zoster ophthalmicus after treatment with autologous serum tear drops. Cornea Open. 2024;3:e0029. https:\/\/doi.org\/10.1097\/coa.0000000000000029.","journal-title":"Cornea Open"},{"key":"2396_CR40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.51329\/mehdiophthal1463","volume":"11","author":"R Kamel Farag","year":"2023","unstructured":"Kamel Farag R, Dawood M, Elesawi M. Safety and efficacy of eye drops from umbilical cord blood platelet lysate to treat resistant corneal ulcer. Med Hypothesis Discov Innov Ophthalmol. 2023;11:189\u2013202. https:\/\/doi.org\/10.51329\/mehdiophthal1463.","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"2396_CR41","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.3390\/polym14224921","volume":"14","author":"I Alcalde","year":"2022","unstructured":"Alcalde I, S\u00e1nchez-Fern\u00e1ndez C, Del Olmo-Aguado S, Mart\u00edn C, Olmiere C, Artime E, et al. Synthetic heparan sulfate mimetic polymer enhances corneal nerve regeneration and wound healing after experimental laser ablation injury in mice. Polymers. 2022;14:4921. https:\/\/doi.org\/10.3390\/polym14224921.","journal-title":"Polymers"},{"key":"2396_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.xjec.2020.03.001","volume":"7","author":"T Kocat\u00fcrk","year":"2020","unstructured":"Kocat\u00fcrk T, Alemdar M, Key \u00d6, \u00c7akmak H, G\u00fcell JL. Matrix regenerating agent (RGTA) plays a prominent role in treating persistent epithelial defects. Journal of EuCornea. 2020;7:17\u201322. https:\/\/doi.org\/10.1016\/j.xjec.2020.03.001.","journal-title":"Journal of EuCornea"},{"key":"2396_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02710-3","volume":"20","author":"HJ Lee","year":"2023","unstructured":"Lee HJ, Kim HJ, Ko JH, Oh JY. Myeloid cells protect corneal nerves against sterile injury through negative-feedback regulation of TLR2\u2013IL-6 axis. J Neuroinflamm. 2023;20:27. https:\/\/doi.org\/10.1186\/s12974-023-02710-3.","journal-title":"J Neuroinflamm"},{"key":"2396_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/cells14211730","volume":"14","author":"H Niktinat","year":"2025","unstructured":"Niktinat H, Alviar M, Kashani M, Massoumi H, Djalilian AR, Jalilian E. Aging and corneal nerve health: mechanisms of degeneration and emerging therapies for the cornea. Cells. 2025;14:1730. https:\/\/doi.org\/10.3390\/cells14211730.","journal-title":"Cells"},{"key":"2396_CR45","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.48378","volume":"8","author":"DJ Royer","year":"2019","unstructured":"Royer DJ, Echegaray-Mendez J, Lin L, Gmyrek GB, Mathew R, Saban DR, et al. Complement and CD4+ T cells drive context-specific corneal sensory neuropathy. Elife. 2019;8:e48378. https:\/\/doi.org\/10.7554\/eLife.48378.","journal-title":"Elife"},{"key":"2396_CR46","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1167\/iovs.13-11681","volume":"54","author":"J Gao","year":"2013","unstructured":"Gao J, Sana R, Calder V, Calonge M, Lee W, Wheeler LA, et al. Mitochondrial permeability transition pore in inflammatory apoptosis of human conjunctival epithelial cells and T cells: effect of cyclosporin A. Invest Ophthalmol Vis Sci. 2013;54:4717\u201333. https:\/\/doi.org\/10.1167\/iovs.13-11681.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2396_CR47","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3182281028","author":"JH Lee","year":"2011","unstructured":"Lee JH, Kim JW, Im YS, Seong GJ, Lee HK. Cyclosporine A induces nerve growth factor expression via activation of MAPK p38 and NFAT5. Cornea. 2011. https:\/\/doi.org\/10.1097\/ICO.0b013e3182281028.","journal-title":"Cornea"},{"key":"2396_CR48","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/ceo.12898","volume":"45","author":"O Levy","year":"2017","unstructured":"Levy O, Labb\u00e9 A, Borderie V, Hamiche T, Dupas B, Laroche L, et al. Increased corneal sub\u2010basal nerve density in patients with Sj\u00f6gren syndrome treated with topical cyclosporine A. Clin Exp Ophthalmol. 2017;45:455\u201363. https:\/\/doi.org\/10.1111\/ceo.12898.","journal-title":"Clin Exp Ophthalmol"},{"key":"2396_CR49","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3928\/1081597X-20080401-04","volume":"24","author":"GA Peyman","year":"2008","unstructured":"Peyman GA, Sanders DR, Batlle JF, F\u00e9liz R, Cabrera G. Cyclosporine 0.05% ophthalmic preparation to aid recovery from loss of corneal sensitivity after LASIK. J Refract Surg. 2008;24:337\u201343. https:\/\/doi.org\/10.3928\/1081597X-20080401-04.","journal-title":"J Refract Surg"},{"key":"2396_CR50","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0002-9394(01)00913-8","volume":"132","author":"D Dursun","year":"2001","unstructured":"Dursun D, Kim MC, Solomon A, Pflugfelder SC. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids. Am J Ophthalmol. 2001;132:8\u201313. https:\/\/doi.org\/10.1016\/S0002-9394(01)00913-8.","journal-title":"Am J Ophthalmol"},{"key":"2396_CR51","unstructured":"OKYO Pharma Ltd. OKYO Pharma unveils strong phase 2 clinical trial results for urcosimod to treat neuropathic corneal pain. 2025. https:\/\/okyopharma.com\/okyo-pharma-unveils-strong-phase-2-clinical-trial-results-for-urcosimod-to-treat-neuropathic-corneal-pain\/. Accessed 5 Sep 2026."},{"key":"2396_CR52","unstructured":"Patil R, Jacob G, Hamrah P. First-in-human study of urcosimod to treat neuropathic corneal pain (NCP) shows clinically meaningful pain reduction and quality-of-life improvement in NCP patients. Invest Ophthalmol Vis Sci. 2026;67(7):3461. https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2815800."},{"key":"2396_CR53","unstructured":"OKYO Pharma Ltd. OKYO Pharma announces new data showing favorable corneal nerve outcomes in phase 2 study for neuropathic corneal pain. 2025. https:\/\/okyopharma.com\/okyo-pharma-announces-new-data-showing-favorable-corneal-nerve-outcomes-in-phase-2-study-for-neuropathic-corneal-pain\/. Accessed 5 Sep 2026."},{"key":"2396_CR54","unstructured":"OKYO Pharma Ltd. FDA authorizes compassionate use of urcosimod (0.05%) for the treatment of neuropathic corneal pain. OKYO Pharma. 2026. https:\/\/okyopharma.com\/fda-approves-compassionate-use-of-urcosimod-0-05-for-the-treatment-of-neuropathic-corneal-pain\/. Accessed 17 Aug 2026."},{"key":"2396_CR55","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.ajo.2006.01.048","volume":"141","author":"SJ Lee","year":"2006","unstructured":"Lee SJ, Kim JK, Seo KY, Kim EK, Lee HK. Comparison of corneal nerve regeneration and sensitivity between LASIK and laser epithelial keratomileusis (LASEK). Am J Ophthalmol. 2006;141:1009-15.e1. https:\/\/doi.org\/10.1016\/j.ajo.2006.01.048.","journal-title":"Am J Ophthalmol"},{"key":"2396_CR56","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1167\/iovs.10-5670","volume":"52","author":"K Xu","year":"2011","unstructured":"Xu K, Yu F-SX. Impaired epithelial wound healing and EGFR signaling pathways in the corneas of diabetic rats. Invest Ophthalmol Vis Sci. 2011;52:3301\u20138. https:\/\/doi.org\/10.1167\/iovs.10-5670.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2396_CR57","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2337\/db13-1260","volume":"63","author":"I Bettahi","year":"2014","unstructured":"Bettahi I, Sun H, Gao N, Wang F, Mi X, Chen W, et al. Genome-wide transcriptional analysis of differentially expressed genes in diabetic, healing corneal epithelial cells: hyperglycemia-suppressed TGF\u03b23 expression contributes to the delay of epithelial wound healing in diabetic corneas. Diabetes. 2014;63:715\u201327. https:\/\/doi.org\/10.2337\/db13-1260.","journal-title":"Diabetes"},{"key":"2396_CR58","first-page":"1020","volume":"14","author":"N Vij","year":"2008","unstructured":"Vij N, Sharma A, Thakkar M, Sinha S, Mohan RR. PDGF-driven proliferation, migration, and IL8 chemokine secretion in human corneal fibroblasts involve JAK2-STAT3 signaling pathway. Mol Vis. 2008;14:1020\u20137.","journal-title":"Mol Vis"},{"key":"2396_CR59","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3892\/ijmm.2016.2769","volume":"38","author":"YL Gu","year":"2016","unstructured":"Gu YL, Gao GQ, Ma N, Ye LL, Zhang LW, Gao X, et al. CNTF protects neurons from hypoxic injury through the activation of STAT3pTyr705. Int J Mol Med. 2016;38:1915\u201321. https:\/\/doi.org\/10.3892\/ijmm.2016.2769.","journal-title":"Int J Mol Med"},{"key":"2396_CR60","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.ophtha.2018.02.022","volume":"125","author":"S Bonini","year":"2018","unstructured":"Bonini S, Lambiase A, Rama P, Sinigaglia F, Allegretti M, Chao W, et al. Phase II randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis. Ophthalmology. 2018;125:1332\u201343. https:\/\/doi.org\/10.1016\/j.ophtha.2018.02.022.","journal-title":"Ophthalmology"},{"key":"2396_CR61","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ophtha.2019.08.020","volume":"127","author":"SC Pflugfelder","year":"2020","unstructured":"Pflugfelder SC, Massaro-Giordano M, Perez VL, Hamrah P, Deng SX, Espandar L, et al. Topical recombinant human nerve growth factor (cenegermin) for neurotrophic keratopathy: a multicenter randomized vehicle-controlled pivotal trial. Ophthalmology. 2020;127:14\u201326. https:\/\/doi.org\/10.1016\/j.ophtha.2019.08.020.","journal-title":"Ophthalmology"},{"key":"2396_CR62","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.exer.2013.12.015","volume":"120","author":"M Reichard","year":"2014","unstructured":"Reichard M, Hovakimyan M, Guthoff RF, Stachs O. In vivo visualisation of murine corneal nerve fibre regeneration in response to ciliary neurotrophic factor. Exp Eye Res. 2014;120:20\u20137. https:\/\/doi.org\/10.1016\/j.exer.2013.12.015.","journal-title":"Exp Eye Res"},{"key":"2396_CR63","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1167\/iovs.09-3641","volume":"51","author":"MS Cortina","year":"2010","unstructured":"Cortina MS, He J, Li N, Bazan NG, Bazan HEP. Neuroprotectin D1 synthesis and corneal nerve regeneration after experimental surgery and treatment with PEDF plus DHA. Invest Ophthalmol Vis Sci. 2010;51:804\u201310. https:\/\/doi.org\/10.1167\/iovs.09-3641.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2396_CR64","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.2337\/db17-0249","volume":"66","author":"J He","year":"2017","unstructured":"He J, Pham TL, Kakazu A, Bazan HEP. Recovery of corneal sensitivity and increase in nerve density and wound healing in diabetic mice after PEDF plus DHA treatment. Diabetes. 2017;66:2511\u201320. https:\/\/doi.org\/10.2337\/db17-0249.","journal-title":"Diabetes"},{"key":"2396_CR65","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3009644","volume":"6","author":"S Basu","year":"2014","unstructured":"Basu S, Hertsenberg AJ, Funderburgh ML, Burrow MK, Mann MM, Du Y, et al. Human limbal biopsy\u2013derived stromal stem cells prevent corneal scarring. Sci Transl Med. 2014;6:266ra172. https:\/\/doi.org\/10.1126\/scitranslmed.3009644.","journal-title":"Sci Transl Med"},{"key":"2396_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56461-1","volume":"16","author":"UV Jurkunas","year":"2025","unstructured":"Jurkunas UV, Kaufman AR, Yin J, Ayala A, Maguire M, Samarakoon L, et al. Cultivated autologous limbal epithelial cell (CALEC) transplantation for limbal stem cell deficiency: a phase I\/II clinical trial of the first xenobiotic-free, serum-free, antibiotic-free manufacturing protocol developed in the US. Nat Commun. 2025;16:1607. https:\/\/doi.org\/10.1038\/s41467-025-56461-1.","journal-title":"Nat Commun"},{"key":"2396_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/srep45396","volume":"7","author":"GH-F Yam","year":"2017","unstructured":"Yam GH-F, Williams GP, Setiawan M, Yusoff NZBM, Lee X, Htoon HM, et al. Nerve regeneration by human corneal stromal keratocytes and stromal fibroblasts. Sci Rep. 2017;7:45396. https:\/\/doi.org\/10.1038\/srep45396.","journal-title":"Sci Rep"},{"key":"2396_CR68","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4103\/JOCO.JOCO_246_20","volume":"33","author":"A Shadmani","year":"2021","unstructured":"Shadmani A, Razmkhah M, Jalalpoor MH, Lari SY, Eghtedari M. Autologous activated omental versus allogeneic adipose tissue-derived mesenchymal stem cells in corneal alkaline injury: an experimental study. J Curr Ophthalmol. 2021;33:136. https:\/\/doi.org\/10.4103\/JOCO.JOCO_246_20.","journal-title":"J Curr Ophthalmol."},{"key":"2396_CR69","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/sctm.18-0297","volume":"8","author":"G Shojaati","year":"2019","unstructured":"Shojaati G, Khandaker I, Funderburgh ML, Mann MM, Basu R, Stolz DB, et al. Mesenchymal stem cells reduce corneal fibrosis and inflammation via extracellular vesicle-mediated delivery of miRNA. Stem Cells Transl Med. 2019;8:1192\u2013201. https:\/\/doi.org\/10.1002\/sctm.18-0297.","journal-title":"Stem Cells Transl Med"},{"key":"2396_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051486","volume":"15","author":"S An","year":"2023","unstructured":"An S, Anwar K, Ashraf M, Lee H, Jung R, Koganti R, et al. Wound-healing effects of mesenchymal stromal cell secretome in the cornea and the role of exosomes. Pharmaceutics. 2023;15:1486. https:\/\/doi.org\/10.3390\/pharmaceutics15051486.","journal-title":"Pharmaceutics"},{"key":"2396_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2026.110931","volume":"266","author":"C-Y Tsai","year":"2026","unstructured":"Tsai C-Y, Yang S-C, Huang W-L, Hou Y-T, Klochkov V, Chen M-Y, et al. Fate of intrastromal injected adipose-derived mesenchymal stem cell and its effects on corneal nerve regeneration: an in vivo confocal microscopy study. Exp Eye Res. 2026;266:110931. https:\/\/doi.org\/10.1016\/j.exer.2026.110931.","journal-title":"Exp Eye Res"},{"key":"2396_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/srep40548","volume":"7","author":"K-Y Han","year":"2017","unstructured":"Han K-Y, Tran JA, Chang J-H, Azar DT, Zieske JD. Potential role of corneal epithelial cell-derived exosomes in corneal wound healing and neovascularization. Sci Rep. 2017;7:40548. https:\/\/doi.org\/10.1038\/srep40548.","journal-title":"Sci Rep"},{"key":"2396_CR73","doi-asserted-by":"publisher","first-page":"20065","DOI":"10.1021\/acsnano.4c00423","volume":"18","author":"F Yu","year":"2024","unstructured":"Yu F, Zhao X, Wang Q, Fang P-H, Liu L, Du X, et al. Engineered mesenchymal stromal cell exosomes-loaded microneedles improve corneal healing after chemical injury. ACS Nano. 2024;18:20065\u201382. https:\/\/doi.org\/10.1021\/acsnano.4c00423.","journal-title":"ACS Nano"},{"key":"2396_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202507451","volume":"22","author":"H Massoumi","year":"2026","unstructured":"Massoumi H, Katz EA, Alviar M, Zhou Q, Oyarzun MG, Tewari D, et al. Corneal nerve regeneration via MSC-derived EVs: tissue source and culture dimensionality dictate miRNA cargo and therapeutic efficacy. Small. 2026;22:e07451. https:\/\/doi.org\/10.1002\/smll.202507451.","journal-title":"Small"},{"key":"2396_CR75","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1097\/IOP.0000000000002064","volume":"38","author":"ES Charlson","year":"2022","unstructured":"Charlson ES, Pepper JP, Kossler AL. Corneal neurotization via dual nerve autografting. Ophthalmic Plast Reconstr Surg. 2022;38:e17\u20139. https:\/\/doi.org\/10.1097\/IOP.0000000000002064.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"2396_CR76","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/SAP.0000000000003117","volume":"88","author":"MA Swanson","year":"2022","unstructured":"Swanson MA, Swanson RD, Kotha VS, Cai Y, Clark R, Jin A, et al. Corneal neurotization: a meta-analysis of outcomes and patient selection factors. Ann Plast Surg. 2022;88:687\u201394. https:\/\/doi.org\/10.1097\/SAP.0000000000003117.","journal-title":"Ann Plast Surg"},{"key":"2396_CR77","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1186\/s40001-025-02992-8","volume":"30","author":"R Kuang","year":"2025","unstructured":"Kuang R, Xu S, Lin X, He B, Xu Y, Zhu Z. Systematic analysis of factors affecting the efficacy of corneal reinnervation surgery in treating neurotrophic keratitis. Eur J Med Res. 2025;30:742. https:\/\/doi.org\/10.1186\/s40001-025-02992-8.","journal-title":"Eur J Med Res"},{"key":"2396_CR78","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1167\/tvst.11.10.17","volume":"11","author":"Y-S Yoo","year":"2022","unstructured":"Yoo Y-S, Park S, Eun P, Park YM, Lim DH, Chung T-Y. Corneal neuro-regenerative effect of transcutaneous electrical stimulation in a rabbit lamellar keratectomy model. Transl Vis Sci Technol. 2022;11:17. https:\/\/doi.org\/10.1167\/tvst.11.10.17.","journal-title":"Transl Vis Sci Technol."},{"key":"2396_CR79","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/dneu.22949","volume":"84","author":"MR Khalili","year":"2024","unstructured":"Khalili MR, Shadmani A, Sanie-Jahromi F. Application of electrostimulation and magnetic stimulation in patients with optic neuropathy: a mechanistic review. Dev Neurobiol. 2024;84:236\u201348. https:\/\/doi.org\/10.1002\/dneu.22949.","journal-title":"Dev Neurobiol"},{"key":"2396_CR80","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1167\/iovs.16-21362","volume":"58","author":"M Brinton","year":"2017","unstructured":"Brinton M, Kossler AL, Patel ZM, Loudin J, Franke M, Ta CN, et al. Enhanced tearing by electrical stimulation of the anterior ethmoid nerve. Invest Ophthalmol Vis Sci. 2017;58:2341\u20138. https:\/\/doi.org\/10.1167\/iovs.16-21362.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2396_CR81","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ymeth.2025.03.011","volume":"238","author":"GF Galv\u00e3o","year":"2025","unstructured":"Galv\u00e3o GF, Mar\u00edngolo ICB, Martins YA, Villarruel Mu\u00f1oz JB, Fantucci MZ, da Silva RR, et al. Iontophoresis impact on corneal properties using an ex vivo bovine eye model. Methods. 2025;238:74\u201383. https:\/\/doi.org\/10.1016\/j.ymeth.2025.03.011.","journal-title":"Methods"},{"key":"2396_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015352","volume":"24","author":"L-C Liu","year":"2023","unstructured":"Liu L-C, Chen Y-H, Lu D-W. Overview of recent advances in nano-based ocular drug delivery. Int J Mol Sci. 2023;24:15352. https:\/\/doi.org\/10.3390\/ijms242015352.","journal-title":"Int J Mol Sci"},{"key":"2396_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-020-01584-w","volume":"20","author":"P Fogagnolo","year":"2020","unstructured":"Fogagnolo P, Melardi E, Tranchina L, Rossetti L. Topical citicoline and vitamin B12 versus placebo in the treatment of diabetes-related corneal nerve damage: a randomized double-blind controlled trial. BMC Ophthalmol. 2020;20:315. https:\/\/doi.org\/10.1186\/s12886-020-01584-w.","journal-title":"BMC Ophthalmol"},{"key":"2396_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1109291","volume":"14","author":"C Bucolo","year":"2023","unstructured":"Bucolo C, Maugeri G, Giunta S, D\u2019Agata V, Drago F, Romano GL. Corneal wound healing and nerve regeneration by novel ophthalmic formulations based on cross-linked sodium hyaluronate, taurine, vitamin B6, and vitamin B12. Front Pharmacol. 2023;14:1109291. https:\/\/doi.org\/10.3389\/fphar.2023.1109291.","journal-title":"Front Pharmacol"},{"key":"2396_CR85","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.2337\/db19-0870","volume":"69","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Gao N, Wu L, Lee PSY, Me R, Dai C, et al. Role of VIP and Sonic Hedgehog signaling pathways in mediating epithelial wound healing, sensory nerve regeneration, and their defects in diabetic corneas. Diabetes. 2020;69:1549\u201361. https:\/\/doi.org\/10.2337\/db19-0870.","journal-title":"Diabetes"},{"key":"2396_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.101039","volume":"89","author":"FX Yu","year":"2022","unstructured":"Yu FX, Lee PSY, Yang L, Gao N, Zhang Y, Ljubimov AV, et al. The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas. Prog Retin Eye Res. 2022;89:101039. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.101039.","journal-title":"Prog Retin Eye Res"},{"key":"2396_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/srep18619","volume":"5","author":"Y Ru","year":"2015","unstructured":"Ru Y, Huang Y, Liu H, Du J, Meng Z, Dou Z, et al. \u03b1-Melanocyte-stimulating hormone ameliorates ocular surface dysfunctions and lesions in a scopolamine-induced dry eye model via PKA-CREB and MEK-Erk pathways. Sci Rep. 2015;5:18619. https:\/\/doi.org\/10.1038\/srep18619.","journal-title":"Sci Rep"},{"key":"2396_CR88","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jtos.2021.08.011","volume":"22","author":"S Mertsch","year":"2021","unstructured":"Mertsch S, Neumann I, Rose C, Schargus M, Geerling G, Schrader S. The effect of Rho kinase inhibition on corneal nerve regeneration in vitro and in vivo. Ocul Surf. 2021;22:213\u201323. https:\/\/doi.org\/10.1016\/j.jtos.2021.08.011.","journal-title":"Ocul Surf"},{"key":"2396_CR89","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3390\/pharmaceutics12080767","volume":"12","author":"P Bastola","year":"2020","unstructured":"Bastola P, Song L, Gilger BC, Hirsch ML. Adeno-associated virus-mediated gene therapy for corneal diseases. Pharmaceutics. 2020;12:767. https:\/\/doi.org\/10.3390\/pharmaceutics12080767.","journal-title":"Pharmaceutics"},{"key":"2396_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/cells12091280","volume":"12","author":"S Sarkar","year":"2023","unstructured":"Sarkar S, Panikker P, D\u2019Souza S, Shetty R, Mohan RR, Ghosh A. Corneal regeneration using gene therapy approaches. Cells. 2023;12:1280. https:\/\/doi.org\/10.3390\/cells12091280.","journal-title":"Cells"},{"key":"2396_CR91","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2337\/db24-0393","volume":"74","author":"L Cong","year":"2025","unstructured":"Cong L, Qi B, Chen S, Liu R, Li S, Zhou Q, et al. Long-term nerve regeneration in diabetic keratopathy mediated by a novel NGF delivery system. Diabetes. 2025;74:22\u201335. https:\/\/doi.org\/10.2337\/db24-0393.","journal-title":"Diabetes"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-026-02396-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-026-02396-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-026-02396-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:11:58Z","timestamp":1792829518000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-026-02396-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":91,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2396"],"URL":"https:\/\/doi.org\/10.1007\/s40265-026-02396-w","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflict of interest to be declared.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AS and HE drafted the initial version of the manuscript and data extraction and collection. AG, MK, AS and HE were actively involved in the critical revision and improving the manuscript. All authors read and approved the final version of the manuscript.","order":7,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Artificial intelligence (AI) tools were used solely to assist with language editing and improving the clarity and readability of the manuscript. All scientific content, concepts, interpretations, conclusions, and intellectual contributions were developed by the authors. The authors reviewed and approved all AI-assisted edits and take full responsibility for the final content of the manuscript.","order":8,"name":"Ethics","label":"AI use","group":{"name":"EthicsHeading","label":"Declarations"}}]}}